about
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T CellsLimitations in the Design of Chimeric Antigen Receptors for Cancer Therapy.Utility of the RIG-I Agonist Triphosphate RNA for Melanoma TherapyCCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodesSystemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model
P50
description
researcher
@en
wetenschapper
@nl
name
Stefan Endres
@en
Stefan Endres
@nl
type
label
Stefan Endres
@en
Stefan Endres
@nl
prefLabel
Stefan Endres
@en
Stefan Endres
@nl
P31
P496
0000-0002-4703-537X